My Fund

Loading your portfolio…

Checking your account and saved picks.

Choose a startup

Explore all 1429 companies in this selection. Research each company before making your pick.

Includes historical VC holdings. A listing does not confirm current ownership or startup stage.

VC tracking →

Showing 1–1 of 1 startup

BIOVENTRIX, INC.

Limited coverage

Biotechnology

On its website, the company describes its work as “Revivent Therapy is an investigational cardiac remodeling technique performed by a cardiothoracic surgeon under general anesthesia. It is designed to treat patients with heart failure…”.

No tracked VC backing recorded
bioventrix.com ↗
Research BIOVENTRIX, INC.

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “Revivent Therapy is an investigational cardiac remodeling technique performed by a cardiothoracic surgeon under general anesthesia. It is designed to treat patients with heart failure…”.

Visit bioventrix.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $1,200,000 · Offering amount as filed: $3,000,000

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗
How it works

Pick up to 50 companies. Your picks are private to your account.

A new US fundraising disclosure (Form D) earns 2 points. A first investment announced by a tracked VC earns 3. Milestones must occur and be observed after your pick.

Measured growth earns 1 point once: the same RiseFinder composite score rises between dated observations after your pick, using one formula version. Where available, a supported public source metric can also qualify. Lower ranks are better; rising counts are better. A completed, dated IPO or acquisition earns 10 points once.

The composite score measures relative public signals on a 0–100 scale. It is not a company valuation. Coverage varies; companies without qualifying history wait for evidence.

Initial imports, old discoveries, follow-ons from existing backers, amendments, undated events and same-day events earn no points.

Points track verified milestones after your pick. They do not represent investment returns.